41 – 50 of 62
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2004
-
Mark
Follow-up of patients treated by cytoreduction and chemotherapy for peritoneal carcinomatosis of colorectal origin
(
- Contribution to journal › Article
- 2003
-
Mark
The cost of treating pancreatic cancer--a cohort study based on patients' records from four hospitals in Sweden.
(
- Contribution to journal › Article
-
Mark
Heat penetration in locally applied hyperthermia in the abdomen during intra-operative hyperthermic intraperitoneal chemotherapy
(
- Contribution to journal › Article
-
Mark
Cytoreductive surgery combined with intraoperative hyperthermic intrathoracic chemotherapy for stage I malignant pleural mesothelioma
(
- Contribution to journal › Article
-
Mark
Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer
2003) In Journal of clinical oncology : official journal of the American Society of Clinical Oncology 21(20). p.43-3737(
- Contribution to journal › Article
- 2002
-
Mark
Anaplastic thyroid carcinoma: three protocols combining doxorubicin, hyperfractionated radiotherapy and surgery.
(
- Contribution to journal › Article
- 2001
-
Mark
Electrically mediated drug delivery for treatment of an adenocarcinoma transplanted into rat liver
(
- Contribution to journal › Article
-
Mark
A new antitumour treatment combining radiation and electric pulses
(
- Contribution to journal › Article
- 2000
-
Mark
Tailored fluorouracil, epirubicin, and cyclophosphamide compared with marrow-supported high-dose chemotherapy as adjuvant treatment for high-risk breast cancer : a randomised trial
(
- Contribution to journal › Article
- 1998
-
Mark
Multimodality treatment of 128 patients with locally advanced breast carcinoma in the era of mammography screening using standard polychemotherapy with 5-fluorouracil, epirubicin, and cyclophosphamide : prognostic and therapeutic implications
(
- Contribution to journal › Article